Select for export Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881117714049 PubMed 28631526 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-06-19 Forstmann M, Sagioglou C. Europe PMC Published psilocybin AddictionWellbeingPersonality Change Observational Study More
Select for export Psilocybin: Good Trip or Bad Trip. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.697 PubMed 28548221 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2017-05-25 Sellers EM. Europe PMC Published psilocybin Pharmacology Other More
Select for export An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116684335 PubMed 28095732 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-01-17 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Observational Study More
Select for export A New Spectrophotometric Method for the Determination of Psilocin and Psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX International Journal of Analytical and Applied Chemistry 2016-12-31 Krishna Lavanya, T.R. Baggi OpenAlex Published psilocybinpsilocin Pharmacology Other More
Select for export Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675512 PubMed 27909164 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675513 PubMed 27909165 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116678781 PubMed 27856683 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-16 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyConsciousness Case Report More
Select for export Role of psilocybin in the treatment of depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316676092 PubMed 28101325 Copy citation Copy BibTeX Therapeutic Advances in Psychopharmacology 2016-10-26 Mahapatra A, Gupta R. Europe PMC Published psilocybin DepressionAnxietyReceptor Pharmacology Other More
Select for export Alterations of consciousness and mystical-type experiences after acute LSD in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-016-4453-0 PubMed 27714429 Copy citation Copy BibTeX Psychopharmacology 2016-10-06 Liechti ME, Dolder PC, Schmid Y. Europe PMC Published psilocybin Brain ImagingConsciousnessAging Observational Study More
Select for export Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(16)31133-6 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-09-30 Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček OpenAlex Published psilocybin Brain ImagingReceptor Pharmacology Other More
Select for export Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(16)31070-7 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-09-30 O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Psilocybin zur Behandlung der therapieresistenten Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0042-110896 Copy citation Copy BibTeX PSYCH up2date 2016-09-07 Authors unavailable OpenAlex Published psilocybin DepressionPharmacology Other More
Select for export Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116662634 PubMed 27578767 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-08-29 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW Europe PMC Published psilocybin WellbeingEmotional ProcessingObservational Study Observational Study More
Select for export Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw016 PubMed 26874330 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-07-04 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Sex differences and serotonergic mechanisms in the behavioural effects of psilocin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/fbp.0000000000000198 PubMed 26461483 Copy citation Copy BibTeX Behavioural Pharmacology 2016-05-31 Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. Europe PMC Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report No abstract availability was recorded for this entry. Details DOI 10.1093/ijnp/pyw041.502 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-05-26 Tomáš Páleníček, Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová OpenAlex Published psilocybin Brain ImagingHealthy Volunteers Other More
Select for export PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw041.506 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-05-26 Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský OpenAlex Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2016.01.005 PubMed 26875114 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-01-21 Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More
Select for export P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(15)30364-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2015-08-31 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other More
Select for export Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-015-4026-7 PubMed 26231498 Copy citation Copy BibTeX Psychopharmacology 2015-07-31 Kometer M, Pokorny T, Seifritz E, Volleinweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Clinical Trial More
